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The relationship between maternal and child immunity has been actively studied in the
context of complications during pregnancy, autoimmune diseases, and haploidentical trans-
plantation of hematopoietic stem cells and solid organs. Here, we have for the first time
used high-throughput Illumina HiSeq sequencing to perform deep quantitative profiling of
T cell receptor (TCR) repertoires for peripheral blood samples of three mothers and their
six children. Advanced technology allowed accurate identification of 5×105 to 2×106 TCR
beta clonotypes per individual. We performed comparative analysis of these TCR reper-
toires with the aim of revealing characteristic features that distinguish related mother-child
pairs, such as relative TCR beta variable segment usage frequency and relative overlap
of TCR beta complementarity-determining region 3 (CDR3) repertoires. We show that
thymic selection essentially and similarly shapes the initial output of the TCR recombi-
nation machinery in both related and unrelated pairs, with minor effect from inherited
differences.The achieved depth ofTCR profiling also allowed us to test the hypothesis that
mature T cells transferred across the placenta during pregnancy can expand and persist
as functional microchimeric clones in their new host, using characteristic TCR beta CDR3
variants as clonal identifiers.
Keywords: TCR repertoires, NGS, maternal-fetal exchange, public clonotypes, T cell receptor, haploidentical
transplantation, autoimmune diseases, microchimerism
INTRODUCTION
Closeness and relationship between mother and child immunity
have been the focus of studies of pregnancy (1), autoimmunity
(2–4) and haploidentical transplantations of hematopoietic stem
cells (HSCs) (5), and solid organs (6, 7).
In recent years, the potential of next-generation sequencing
(NGS) to reveal the full complexity of human and mouse immune
receptor repertoires has inspired numerous efforts to develop opti-
mal techniques for achieving large-scale T cell receptor (TCR)
and antibody profiling (8–12) and to decipher various aspects
of adaptive immunity (8, 9, 11, 13–17). With appropriate library
preparation methods (18), NGS techniques now make it possible
to perform quantitative analysis of hundreds of thousands or mil-
lions of distinct TCR beta complementarity-determining region
3 (CDR3) variants. This individual diversity of TCR beta CDR3
variants, which is generated in the course of V-D-J recombination
and the random addition and deletion of nucleotides in the thy-
mus, largely determines the whole diversity of naïve T cells and
specificity of T cell immune responses (19, 20).
In the present study, we have used deep NGS profiling to com-
pare TCR beta repertoires of mothers and their children. We
achieved a profiling depth of 500,000–2,000,000 unique TCR beta
CDR3 clonotypes per donor, and performed comparative analy-
sis with the aim of revealing specific features of TCR repertoires
that distinguish related mother-child pairs from unrelated indi-
viduals, and how these familial repertoires manifest the influence
of inherited factors, such as the elements of TCR recombination
machinery and human leukocyte antigens (HLA). By comparing
out-of-frame (i.e., non-functional and thus not subjected to selec-
tion) and in-frame TCR beta repertoires, we also show the extent
of the impact of thymic selection and the common trends in how
this process shapes individual repertoires.
Additionally, the profiling depth that we achieved allowed us to
look for the potential presence of maternal or fetal microchimeric
T cell clones that may have transmigrated through the placenta as
mature α/β T cells and which subsequently persist in both related
donors, by using characteristic TCR beta CDR3 variants as clonal
identifiers.
MATERIALS AND METHODS
SAMPLE COLLECTION
This study was approved by the ethical committee of the Fed-
eral Scientific Clinical Center of Pediatric Hematology, Oncology,
and Immunology. Blood donors provided informed consent prior
to participating in the study. Ten milliliters of peripheral blood
samples were obtained from nine systemically healthy Caucasian
donors: three mothers (average age 40± 4 years) and their six chil-
dren (average age 11± 4 years). Peripheral blood mononuclear
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cells (PBMCs) were isolated by Ficoll-Paque (Paneco, Russia) den-
sity gradient centrifugation. Total RNA was isolated with Trizol
(Invitrogen, USA) in accordance with the manufacturer’s protocol.
CONTAMINATION PRECAUTIONS
T cell receptor beta libraries were generated in clean PCR hoods
with laminar flow, using reagents of high purity and pipette tips
with hydrophobic filters. As an additional precaution, we gener-
ated the TCR beta libraries for the two groups being compared –
mothers and their children – a month apart, and sequenced the two
libraries in two separate Illumina runs to guarantee the absence of
inter-library contamination during amplification or on the solid
phase of the sequencer.
PREPARING cDNA LIBRARIES FOR QUANTITATIVE TCR BETA PROFILING
cDNA-based library preparation was performed essentially as
described previously (9, 12, 16, 18, 21, 22). Briefly, we used the
Mint kit (Evrogen, Russia) for first-strand cDNA synthesis. For
each donor sample, the whole amount of extracted RNA was used
for cDNA synthesis, with 1.5µg of RNA per 15µl reaction volume.
We incubated the mixture of RNA and priming oligonucleotide
BC_R4_short (GTATCTGGAGTCATTGA), which is specific to
both variants of the human TCR beta constant (TRBC) segment,
at 70°C for 2 min and 42°C for 2 min for annealing. We then added
the 5′-adapter for the template switch. The reaction was carried out
at 42°C for 2 h, with 5µl of IP solution added after the first 40 min.
Further cDNA library amplification was performed in two
sequential PCRs using Encyclo PCR mix (Evrogen). To capture
the maximum number of input cDNA molecules, we used the
whole amount of synthesized cDNA for the first PCR amplifi-
cation. The first PCR totaled 18 cycles with universal primers
M1SS (AAGCAGTGGTATCAACGCA) and BC2R (TGCTTCT-
GATGGCTCAAACAC), which are respectively specific to the 5′-
adapter and a nested region of the TRBC segments. The primer
annealing temperature was set at 62°C. The products of the
first PCR were combined, and a 100-µl aliquot was purified by
QIAquick PCR purification Kit (Qiagen) and eluted by 20µl of
EB buffer.
The second PCR amplification was performed for 8–10 cycles
with a mix of TCR beta joining (TRBJ)-specific primers and the
universal primer M1S ((N)2–4(XXXXX)CAGTGGTATCAACGCA
GAG), which is specific to the 5′-adapter and is nested relative
to the M1SS primer used in the first PCR amplification. XXXXX
represents a sample barcode introduced in the second PCR, and
(N)2–4 are random nucleotides that were added in order to gen-
erate diversity for better cluster identification during Illumina
sequencing. Primer annealing temperature was set at 62°C.
ILLUMINA HiSeq SEQUENCING
PCR products carrying pre-introduced sample barcodes were
mixed together in equal ratio for each of the two groups (moth-
ers and children). Illumina adapters were ligated according to the
manufacturer’s protocol using NEBNext DNA Library Prep Mas-
ter Mix Set for Illumina (New England Biolabs, USA). Generated
libraries were analyzed using two separate Illumina HiSeq 2000
lanes in separate runs with 100+ 100 nt paired end sequencing
using Illumina sequencing primers. Raw sequences deposited in
NCBI SRA database (PRJNA229070).
NGS DATA ANALYSIS
TCR beta variable (TRBV) segment identification [using IMGT
nomenclature (23)], CDR3 identification (based on the sequence
between conserved Cys-104 and Phe-118, inclusive), clonotype
clusterization and correction of reverse transcription, PCR, and
sequencing errors were performed using our MiTCR software
(24)1. The sequencing quality threshold of each nucleotide within
the CDR3 region was set as Phred>25, with low-quality sequence
rescue by mapping to high-quality clonotypes. The strictest “elim-
inate these errors”correction algorithm was employed to eliminate
the maximal number of accumulated PCR and sequencing errors.
STATISTICAL ANALYSIS
We used Jensen–Shannon divergence (JS), which is a symmetrized
version of the Kullback–Leibler divergence (KL), to quantify the
similarity between the clonotype TRBV gene usage distribution in
related and unrelated mother-child pairs. JS and KL are defined as
follows (25):
JS (P , Q) = 1
2
(
KL
(
P ,
P + Q
2
)
+ KL
(
Q,
P + Q
2
))
,
KL (P , Q) =
∑
i
pi log2
pi
qi
.
Where P and Q correspond to the TRBV gene segment fre-
quency distributions of the two individuals being analyzed, and pi
and qi stand for the frequency of a particular TRBV gene segment
in the first and second individual, correspondingly. For statistical
comparison of the JS among related and unrelated mother-child
pairs, we used two-tailed, unpaired Student’s t -test with P-values
<0.05 considered significant. To account for multiple testing,
Bonferroni-corrected P-values were used.
We used linear regression to analyze dependency between
TRBV-CDR3/CDR3 overlap ratio and the number of shared major
histocompatibility complex I (MHC-I) alleles, and calculated the
Pearson correlation coefficient. The linear model:
TRBV− CDR3/CDR3 overlap ratio = b0+ b1
× [Number of shared MHC alleles]
was fit using the least-squares method. Linear regression and cor-
relation analysis were performed using R programing language2.
FACS ANALYSIS
We used the following anti-human antibodies: CD3-PC7 (clone
UCHT1, eBioscience), CD27-PC5 (clone 1A4CD27, Invitrogen),
CD4-PE (clone 13B8.2, Beckman Coulter), CD45RA FITC (eBio-
science, clone JS-B3). An aliquot of PBMC was incubated with
antibodies for 20 min at room temperature, washed twice with
PBS and analyzed via Cytomics FC 500 (Beckman Coulter).
HLA TYPING
The samples were HLA-typed using SSP AllSet Gold HLA-ABC
Low Res Kit and SSP AllSet Gold HLA-DRDQ Low Res Kit
(Invitrogen) and results were processed using UniMatch software.
1http://mitcr.milaboratory.com/
2http://www.R-project.org/
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RESULTS
We obtained at least 1× 107 TCR beta CDR3-containing sequenc-
ing reads for each mother and about 3× 106 reads for each child.
MiTCR software analysis yielded 500,000–2,000,000 distinct TCR
beta CDR3 clonotypes per donor (Table 1) – representing a sig-
nificant portion of the total TCR beta diversity for an individual,
which lower bound estimate constitutes ~4 million (8). We then
subjected these individual TCR beta datasets to comparative analy-
sis in an effort to identify features that distinguish TCR beta
repertoires of related mother-child pairs.
TRBV GENE USAGE
We analyzed the relative usage of TRBV gene segments in
mother-child pairs at three levels (see Figure 1):
Out-of-frame TCR beta variants
The influence of genetic effects on the recombination machinery,
which determines the relative frequencies of TRBV gene segment
usage in TCRs generated before selection in the thymus, should
be reflected by out-of-frame TCR variants that are not subjected
to the pressure of further selective processes. Due to nonsense-
mediated decay mechanisms, RNA-based libraries generally con-
tain a low percentage of out-of-frame TCR beta variants (9, 12,
26, 27). Nevertheless, out-of-frame CDR3 sequences constituted
~2.5% of all clonotypes (Table 1) – 16,048–45,300 clonotypes
per donor – which is sufficiently abundant to perform statistical
analysis. These subsets were used to compare TRBV gene segment
usage in related and unrelated mother-child pairs before thymic
selection.
At this level of out-of-frame non-functional TCR beta variants,
Jensen–Shannon divergence in TRBV gene usage was compara-
ble for related and unrelated mother-child pairs, albeit with a
non-significant increase in divergence for the latter (Figure 2A;
Figures 3A,B, first 2 bars).
Low-frequency in-frame clonotypes
The pressure of thymic selection can be tracked by comparing
TRBV gene segment usage in out-of-frame TCR beta variants
relative to those variants represented in naïve T cells. In this work,
we did not perform separate TCR profiling of FACS-sorted naïve T
cells. We aimed to achieve maximal depth of analysis, and sought
to avoid the loss of cells and RNA and general quantitative biases
that inevitably arise from the cell sorting process. We estimated
the pool of TCR beta clonotypes that predominantly belong to
the naïve subset as follows. We used FACS analysis to identify the
percentage of naïve CD27highCD45RAhigh CD3+ T cells for each
donor (28). This analysis demonstrated that naïve T cells consti-
tute 40–73% of the T cell population in children and 27–55% of
the T cell population in mothers (Table 1; Figure 1). Since each
naïve T cell clone is usually represented by minor numbers of
TCR-identical cells in an individual (29), for the purposes of bulk
analysis, we hypothesized that the subset of the low-frequency
clonotypes that occupies the same share of homeostatic space as
the FACS-determined share of naïve T cells for that particular
donor (433,293–1,797,650 clonotypes per donor) predominantly
includes naïve T cells.
At this level of low-frequency, in-frame TCR beta clonotypes,
TRBV gene segment usage was significantly less divergent com-
pared to out-of-frame TCR beta variants, both in related and
unrelated pairs (Figures 2B and 3). Additionally, TRBV gene
segment usage was significantly more similar for related versus
unrelated pairs (Figures 3A,B, bars 3, 4). In accordance with
JS analysis, comparison within related triplets revealed equal-
ization of the usage of particular TRBV gene segments in low-
frequency, in-frame TCR clonotypes compared to out-of-frame
TCR variants (Figure 4). For example, in each triplet, we saw
the usage of TRBV gene segments 12-3, 12-4, 20-1, 21-1, and
23-1 equalize in the low-frequency TCR beta clonotypes pool.
We also observed an equalizing decrease in TRBV 7-3 usage in
triplets A and C, and an equalizing increase in TRBV 28 usage in
triplet B.
Notably, the observed changes in TRBV gene segments usage
were generally similar in different unrelated donors (compare
Figures 4A–C), and the convergence of TRBV usage after thymic
selection (difference of out-of-frame versus in-frame TRBV usage
divergence) was not significantly dependent on the number of
shared HLA alleles (R= 0.12, P = 0.63).
High-frequency in-frame clonotypes
The influence of antigen-specific reactions on selection of TRBV
gene segments could be tracked by comparing TRBV gene usage
in naïve and antigen-experienced T cells. Following the same logic
Table 1 | Sequencing results:TCR beta reads and clonotypes.
Donor Sex Age Paired end
sequencing
reads
TCR beta CDR3-
containing reads
(%)
TCR beta
clonotypes
before error
correction
FinalTCR
beta
clonotypes
% Of out-of-frame
clonotypes
of all clonotypes
% Of naïve
T cells of all
T cells
(FACS analysis)
% Occupied by
>0.001%
clonotypes,
of all reads
Mother A F 36 13,656,054 12,513,543 (91.6) 2,044,290 1,708,037 2.7 55.0 19.4
Mother B F 43 13,872,805 12,901,795 (93.0) 1,213,738 918,557 2.6 27.3 46.2
Mother C F 43 11,167,059 10,038,463 (89.9) 2,180,886 1,978,745 3.0 39.4 38.2
Child A1 M 11 4,687,578 2,889,352 (61.6) 756,772 729,800 2.6 57.2 16.4
Child A2 M 9 4,202,419 2,467,388 (58.7) 558,173 535,283 2.4 43.0 28.2
Child B1 M 16 4,830,536 3,173,376 (65.7) 821,908 790,592 3.2 60.9 17.2
Child B2 M 10 4,615,093 3,009,961 (65.2) 545,730 517,410 2.3 40.1 34.3
Child C1 F 6 6,081,365 3,940,367 (64.8) 1,104,982 1,060,854 2.3 73.7 13.9
Child C2 M 16 4,564,646 3,008,748 (65.9) 785,164 760,572 2.6 63.7 19.7
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FIGURE 1 | Representation ofT cell clones of different size in
individualTCR beta repertoires. Colored bars represent the share of
clonal space occupied by clones of given type (classified by size) for each
of the nine donors. Light green bars represent the share of naïve
CD27highCD45RAhigh T cells as determined by FACS analysis. Dashed lines
indicate the share of low-frequency TCR beta clonotypes equivalent to
this population in each individual, which were included in “low-frequency
in-frame clonotypes” analysis. Square brackets indicate the share
occupied by high-frequency T cell clones each representing >0.001% of
all T cells.
that we used above for the approximate identification of the subset
of naïve TCR beta clonotypes,we hypothesized that the most abun-
dant clonotypes predominantly represent antigen-experienced T
cell clones. We defined this population as clones representing
>0.001% of all CDR3 sequences. Thus, the lower bound for this
group was approximately an order of magnitude greater than the
upper border set for the low-frequency clones in a given donor’s T
cell pool (Figure 1). Such delineation with a gap between the two
subsets minimized“contamination”by naïve TCR beta clonotypes.
Still, the pool of high-frequency in-frame clonotypes could con-
tain a portion of naïve clonotypes with TCR beta CDR3 sequence
variants of low complexity, that are repetitively produced in thy-
mus due to the convergent recombination events and thus may be
highly represented (15).
This set of the 2,803–8,285 most abundant clonotypes per
individual cumulatively occupied 13.9–46.2% of the homeosta-
tic T cell space in each donor. These high-frequency TCR beta
clonotypes were generally characterized by increased variability in
TRBV gene segment usage,and related and unrelated mother-child
pairs were nearly indistinguishable (Figure 2C; Figures 3A,B, bars
5, 6).
OVERLAP OF TCR BETA REPERTOIRES FOR RELATED AND UNRELATED
MOTHER-CHILD PAIRS
Several studies in recent years have revealed that unrelated individ-
uals widely share TCR beta repertoires (13–15, 30–32). However,
it is presently unclear whether the repertoires of haploidentical
individuals are characterized by a higher level of overlap com-
pared to unrelated donors. Additionally, for related mother-child
pairs, shared TCR beta variants could conceal microchimeric T
cell clones that have been physically shared across the placenta
(see below).
To address these questions, we performed comparative analy-
sis of TCR beta repertoire overlap for related and unrelated
mother-child pairs by quantifying CDR3 variant identity at the
amino acid level, at the nucleotide level, and at the nucleotide
level in conjunction with identical TRBV and TRBJ gene segment
usage (i.e., fully identical TCR beta chains). We measured over-
laps separately for low-frequency and high-frequency in-frame
clonotypes (as delineated in Figure 1), and all in-frame clonotypes.
Table 2 shows raw, non-normalized numbers of CDR3 vari-
ants shared on average by related and unrelated mother-child
pairs.
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FIGURE 2 | Relative similarity ofTRBV gene segments usage
analyzed using the Jensen–Shannon divergence method for
(A) out-of-frameTCR beta variants; (B) Low-frequency in-frameTCR
beta clonotypes; and (C) high-frequency in-frameTCR beta
clonotypes. The central dot in each diagram represents Mother
(A) (orange), (B) (blue), or (C) (green). Surrounding dots represent the
six children. Related children are shown in the same color as their
mothers. The closer the “child” dot is to the central “mother” dot, the
lower the Jensen–Shannon divergence (i.e., more similar TRBV gene
segment usage).
For comparative analysis of relative overlap between subsets
of different size, we normalized the number of identical CDR3
variants based on the sizes of the cross-compared samples as
follows:
Formula 1: [normalized overlap between TCR sets A and B]
= [overlap between TCR sets A and B]/([number of
clonotypes in set A] × [number of clonotypes in set B]).
Normalized results are plotted in Figure 5. For all CDR3 cate-
gories, the degree of overlap was always slightly higher for related
pairs, but this difference never approached a significant level com-
pared to unrelated pairs. The highest level of overlap was observed
for high-frequency clonotypes, in agreement with the previous
work (15).
WITHIN AMINO ACID CDR3 OVERLAPS OF EXPANDED CLONOTYPES,
PERCENTAGE OF CLONOTYPES WITH IDENTICAL TRBV GENES IS
INCREASED FOR RELATED MOTHER-CHILD PAIRS
The CDR3 region is considered to form interactions mainly with
antigenic peptide, while CDR1 and CDR2 encoded in the TRBV
segment are mostly responsible for MHC recognition (33–35).
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FIGURE 3 | Mean Jensen–Shannon divergence forTRBV gene segment
usage for related (R, gray) versus unrelated (UR, blue) mother-child
pairs, with SD. Bonferroni-corrected P -values are provided to account for
multiple testing. (A) Comparison of TRBV gene segment usage frequencies
at the level of distinct TCR beta clonotypes (but not sequencing reads, so
that the influence of relative TCR beta clonotype size within a given
repertoire is excluded). (B) Comparison of TRBV gene segment usage
frequencies at the level of sequencing reads, i.e., considering relative
abundance of clonotypes in peripheral blood. The lower the
Jensen–Shannon divergence, the more similar the TRBV gene segment
usage. *Denotes statistical significance. See Figure 1 for delineation of low-
and high-frequency clonotypes. Please note that “All in-frame clonotypes”
include not only low-frequency and high-frequency clonotypes, but also the
medium-frequency ones.
Some TRBV segments have nearly identical sequences taking
part in CDR3 formation, so two different TRBV segments can
often give rise to the same CDR3 amino acid sequence. How-
ever, in two individuals with similar or identical HLA alleles,
proliferating antigen-specific clones with the same TRBV seg-
ment and CDR3 amino acid sequence that recognize the same
peptide-MHC complex can be preferentially activated (36). There-
fore, since related mother and child pairs share at least 50%
of their HLA alleles, we could expect that antigen-experienced
clones with identical amino acid CDR3 variants that recognize
the same antigenic peptide should more often carry the same
TRBV segment encoding CDR1 and CDR2 responsible for MHC
recognition.
To verify this hypothesis, we analyzed various repertoire pairs
comprising the 10,000 most abundant amino acid CDR3 clono-
types from each individual and computed overlap in terms of
shared amino acid CDR3 sequences and shared amino acid CDR3
sequences carrying the same TRBV segment (i.e., identical CDR1,
2, and 3). We then determined the ratio of TRBV-CDR3 over-
lap to CDR3 overlap for each mother-child pair. In all cases,
the ratio was greater for related mother-child pairs (1.3-fold,
±0.16, Figure 6A). Moreover, we observed significant positive
correlation of this ratio with the number of shared MHC-
I alleles between individuals (R= 0.62, P < 0.006, Figure 6B;
Table 3).
SELECTION IN THE THYMUS DECREASES AVERAGE CDR3 LENGTH
COMPARED TO THE INITIALLY GENERATED REPERTOIRE
Comparison of the out-of-frame and in-frame CDR3 repertoires
revealed that the former are characterized by higher average length
(45.6± 0.4 versus 43.3± 0.2) and an increased number of added
nucleotides (8.6± 0.2 versus 7.4± 0.1, see Figure 7A), in both
mothers and children.
This finding indicates that, upon recombination, the initially
generated TCR beta CDR3 repertoire (the parameters of which
are preserved in the non-functional out-of-frame repertoire) is
characterized by higher average length, while further selection in
thymus essentially shapes the repertoire toward lower CDR3 length
and fewer added nucleotides.
SEARCHING FOR MICROCHIMERIC CLONES TRANSFERRED ACROSS
THE PLACENTA AS MATURE T CELLS
It is well established that mother and child exchange cells across the
placenta during pregnancy (37–42), and that the progeny of these
migrating cells persist in the new host for decades after gestation
(43–45).
Most authors agree that lymphoid progenitor cells commonly
cross the placenta to populate the new host (45–48). Some obser-
vations also indicate that mature T cells can transmigrate through
the placenta (see Discussion). However, it remains to be deter-
mined whether the transferred mature T cells (hereinafter referred
to as mature-microchimeric T cells) can further persist and serve
as functional T cell clones in their new host.
We hypothesized that the present deep sequence analy-
sis of such a substantial portion of the maternal and fetal
TCR repertoire (including the absolute majority of proliferated
antigen-experienced T cell clones) could reveal the presence of
transferred and multiplied functional T cell populations, albeit
without the immediate ability to distinguish the direction of
transfer (i.e., maternal versus fetal microchimerism). Indeed,
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FIGURE 4 |TRBV gene segment usage in functional low-frequencyTCR
beta clonotypes in comparison to out-of-frameTCR variants. Colored bars
indicate the representation of a particular TRBV gene segment family in
out-of-frame TCR variants from each individual. Lines represent alterations in
TRBV gene segment representation in functional low-frequency TCR beta
clonotypes relative to out-of-frame TCR variants. (A), (B), and (C) depict TRBV
gene segment usage for related donors from family (A), (B), and (C),
respectively.
microchimeric T cell clones that were initially transferred across
the placenta as mature T cells (mature-microchimeric T cell
clones) within a given mother-child pair should be characterized
by the same TCR beta CDR3 nucleotide sequence and the same
TRBV and TRBJ gene segments, which therefore could serve as a
clone-specific identifier.
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Table 2 | Average number of sharedTCR beta CDR3 clonotypes in related and unrelated pairs.
Pairs Amino acid Nucleotide NucleotideTRBV,TRBJ identical
Low-
frequency
High-
frequency
All
clonotypes
Low-
frequency
High-
frequency
All
clonotypes
Low-
frequency
High-
frequency
All
clonotypes
Related 71,714±25,890 117±34 83,257±26,056 4,938±2,237 69±7 8,407±3,396 2,015±893 40±10 3,456±1,359
Unrelated 68,979±18,822 99±15 80,304±18,626 4,640±1,587 59±12 7,955±2,227 1,823±624 31±11 3,135±897
Nucleotide CDR3 clonotypesAmino-acid CDR3 clonotypes TRBV-, TRBJ - identical nucleotide
CDR3 clonotypes
low
frequency
high
frequency
all
clonotypes
low
frequency
high
frequency
all
clonotypes
low
frequency
high
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all
clonotypes
R UR R UR R UR R UR R UR R UR R UR R UR R UR
n
o
rm
a
liz
e
d
 o
v
e
rl
a
p
 
10-9
10-8
10-7
10-6
10-5
10-4
FIGURE 5 | Normalized overlap of individualTCR beta repertoires. Overlaps are shown at the level of CDR3 amino acid sequences, nucleotide sequences,
and nucleotide sequences with identical TRBV and TRBJ segments; for related (gray) versus unrelated (blue) mother-child pairs; and for low-frequency,
high-frequency, and all in-frame clonotypes. The number of intersections was normalized as described in Formula 1. R, related pairs; UR, unrelated pairs.
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FIGURE 6 | Amino acidTRBV-CDR3/CDR3 overlap ratio. (A)The ratio
of TRBV-CDR3 overlap to CDR3 overlap for all possible mother-child pairs,
based on the 10,000 most highly represented clonotypes from each
donor. Related mother-child pairs had a higher ratio relative to children
with either of the unrelated mothers. (B)The number of shared MHC-I
alleles in mother-child pairs correlates with the TRBV-CDR3/CDR3 overlap
ratio for the 10,000 most abundant CDR3 clonotypes. Solid line displays
linear regression fit; the Pearson correlation coefficient was 0.62
(P < 0.006). Related and unrelated pairs are shown in gray and black,
respectively.
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Table 3 | HLA typing.
HLA-A HLA-B HLA-C DRB1 DRB3 DRB4 DQB1
Mother A 02, 24 15, 57 03, 06 07, 14 01–03 01 03, 05
Mother B 02, 23 44, 51 02, 04 07, 11 01–03 01-02 02, 03
Mother C 01, 11 08, 35 04/08, 07 01, 03 01–03 – 02, 05
Child A1 02, 25 15, 18 03, 12 04, 14 01–03 01–02 03, 05
Child A2 02, 02 15, 44 03, 05 11, 14 01–03 – 03, 05
Child B1 02, 23 38, 44 04, 12 07, 13 01–03 01–02 02, 06
Child B2 02, 23 27, 44 02, 04 07, 11 01–03 01–02 02, 03
Child C1 02, 11 35, 38 04, 12 01, 13 01–03 – 05, 06
Child C2 02, 11 35, 38 04, 12 01, 13 01–03 - 05, 06
However, ~40% of the CDR3 nucleotide variants shared
between any two individuals were characterized with the same
TRBV and TRBJ gene segments, in similar numbers for both
related and unrelated mother-child pairs. This means 1,766–
5,410 shared clonotype variants across different donor pairs
(Table 2; Figure 5). This widespread sharing of identical TCR
beta nucleotide variants makes the TRBV-CDR3-TRBJ identifier
insufficient to distinguish clones that were physically transferred
across the placenta as mature T cells with recombined TCRs
from public TCRs resulting from independent convergent recom-
bination events (15, 32). Thus, if mature-microchimeric T cell
clones are present, they are concealed amongst the overwhelming
majority of natural public TCRs, and additional characteristics are
needed to delineate them.
It has been reported that public TCR beta clonotypes are gener-
ally characterized by a low number of added nucleotides in CDR3
(i.e., low complexity) (14, 15, 32). We therefore used the num-
ber of added nucleotides as an additional selective characteristic
that essentially determines the probability of convergent recom-
bination events leading to CDR3 variants that are identical at the
nucleotide level (32, 49). Comparison of this characteristic for all
TCR beta CDR3 nucleotide variants and those TRBV-CDR3-TRBJ
nucleotide variants that were shared between unrelated mother-
child pairs revealed that the latter were characterized by much
lower numbers of added nucleotides (Figure 7A).
The transfer of mature T cells across the placenta should not be
dependent on CDR3 length or the number of added nucleotides.
In humans, it has been demonstrated that there is no significant
difference between adult blood and cord blood samples in the
mean number of added nucleotides (50). Therefore, this char-
acteristic should be essentially identical for both feto-maternal
and materno-fetal mature-microchimeric T cell clones and for
the general TCR beta repertoire. If the TCR beta repertoires
of related mother-child pairs carry mature-microchimeric T cell
clones of interest, we would expect to observe shaping of the added
nucleotide curve proportional to the contribution of such clones
to the repertoire overlap (Figure 7B).
The sensitivity of this method to the percentage of mature-
microchimeric T cell clones in the shared TCR beta population is
therefore limited by the natural dispersion of the added nucleotide
curves for unrelated pairs. For example, if mature-microchimeric
T cell clones contribute ~0.3% of the TRBV-CDR3-TRBJ over-
lap for a mother-child pair (i.e., ~10 out of 3,000 overlapping
clonotypes, out of the ~1× 106 total clonotypes sequenced from
each donor), the shape of the added nucleotide curve would be
indistinguishable from that of an unrelated donor pair – and
therefore below the sensitivity threshold of this method. In con-
trast, the presence of 100 mature-microchimeric T cell clones out
of 3,000 clonotypes (i.e., 3.3% of shared variants) per pair of
related donors could be clearly distinguished (Figure 7B), and
this can therefore be considered as the approximate sensitivity
limit of the method. We subsequently determined that the pres-
ence of mature-microchimeric T cell clones is undetectable in all
cases, based on the added nucleotide curves for overlapping TRBV-
CDR3-TRBJ nucleotide sequences for our six related mother-child
pairs (Figure 7C). Correspondingly, the average numbers of added
nucleotides in the shared TRBV-CDR3-TRBJ nucleotide variants
were indistinguishable for related versus unrelated mother-child
pairs (data not shown).
The above-described comparison of added nucleotide curves
was performed at the level of distinct TCR beta clonotypes, but
not sequencing reads, so that the influence of each T cell clone’s
relative representation within the repertoire was excluded. Similar
albeit noisier results we have obtained when performing the same
analysis at the level of sequencing reads (i.e., taking into account
relative clonal size).
As such, we have not identified any meaningful difference
between the subsets of shared TRBV-CDR3-TRBJ nucleotide vari-
ants for related versus unrelated mother-child pairs that would
allow us to establish detection of a subpopulation of mature-
microchimeric T cells that have been systemically shared dur-
ing pregnancy as mature naïve or memory T cells, and which
subsequently have engrafted and survived for years.
DISCUSSION
TRBV GENE USAGE
For out-of-frame TCR beta variants, which are not expressed and
thus avoid any selection, TRBV gene usage was slightly more simi-
lar but generally comparable for related versus unrelated mother-
child pairs (Figures 2A and 3). This indicates that inherited mater-
nal factors associated with the TCR recombination machinery are
insufficient to yield the essentially similar TRBV gene segment
selection in the child.
Remarkably, both within related and unrelated pairs, TRBV
gene segment usage in low-frequency in-frame TCR beta clono-
types was more similar compared to that in the out-of-frame TCR
beta variants (Figure 3). The equalization of the usage of TRBV
gene segments in functional TCR variants (Figure 4) is probably a
manifestation of selective pressure during thymic T cell selection,
which should distinguish TRBV gene usage in functional TCRs
from that preserved in unselected, out-of-frame TCR beta variants.
This pressure on relative TRBV usage frequencies was prominent
and led to significant convergence in both related (P = 0.0006)
and unrelated (P = 0.0015) pairs, indicating that thymic selec-
tion essentially and similarly shapes the initial output of the TCR
recombination machinery at the population level.
Interestingly, thymic selection also essentially filters out the
longest CDR3 variants with large numbers of added nucleotides,
as can be concluded from our comparison of non-functional out-
of-frame and in-frame TCR beta CDR3 repertoires (Figure 7A).
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FIGURE 7 | Added nucleotide curves. (A) Average distribution of added
nucleotides within CDR3 for individual TCR beta repertoires (in-frame: black
solid line; out-of-frame: black dashed line) and for TCR beta clonotypes shared
between unrelated individuals (gray). (B) Modeling of added nucleotide
curves for shared TRBV-CDR3-TRBJ variants between mother-child pairs
based on input of mature-microchimeric TCR beta CDR3 variants in different
proportions. This was derived from the curves in (A), which depict added
nucleotide distributions for shared clonotypes between unrelated individuals
(gray; equivalent to near-zero contribution to shared clonotypes) and for any
individual repertoire (black; equivalent to 100% contribution to shared
clonotypes), mixed in different proportions. Lines represent model input
where mature-microchimeric TCR beta is equal to 100, 33, 3.3, or 0.3% of
shared clonotypes. Shaded region shows the range for unrelated pairs. Inset
shows a magnified view. (C) Added nucleotide curves for TRBV-CDR3-TRBJ
variants shared in each related mother-child pair. Shaded region shows the
range for unrelated pairs.
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Since TRBV gene segments encode the fragments of TCR chains
that interact with MHC (33–35), we would expect that related
mother-child pairs, being haploidentical (i.e., sharing at least 50%
of HLA alleles), are characterized by more similar TRBV gene seg-
ment usage frequencies at the level of functional T cells compared
to unrelated donor pairs due to the impact of identical HLA genes
in thymic selection. Indeed, we observed that differences in TRBV
gene segment usage in related versus unrelated pairs became more
pronounced and statistically significant (P = 0.02) at the level of
low-frequency, in-frame TCR beta CDR3 clonotypes (Figure 3).
However, the general direction of TCR beta repertoire shaping
was similar for related and unrelated donors, suggesting that the
pressure of thymic selection is relatively homogenous in the popu-
lation. The strength of this general pressure was far greater relative
to the specific changes that were characteristic of related donors,
which only added a minor codirectional trend (Figures 3 and 4).
The subset of high-frequency TCR beta clonotypes was char-
acterized by increased variability in TRBV segment usage, and
related and unrelated mother-child pairs were indistinguishable at
this level (Figures 2C and 3). This is presumably due to the fact that
different antigen specificities (but not TRBV segment interaction
with MHC) play a dominant role in the priming and expansion
of T cell clones, and this semi-random process negates the initial
correlations that we observed in TRBV gene usage at the level of
naïve T cells.
It should be noted, however, that the above analysis refers to
low- and high-frequency clonotypes, which do not fully coincide
with the naïve and antigen-experienced T cell subsets, respectively.
It was previously demonstrated in other studies that recombina-
torial biases might result in relatively high frequencies for certain
naïve T cell clones, whereas some memory T cell clones may occur
at relatively low frequencies (11, 14, 15). Moreover, these studies
have shown a substantial overlap between the naïve and memory T
cell repertoires, which suggests that a number of TCR beta CDR3
clonotypes could be associated with both subsets, being paired
with either the same or alternative TCR alpha chains.
OVERLAP OF TCR BETA REPERTOIRES
We observed the greatest relative overlap of TCR beta reper-
toires among high-frequency clonotypes. This observation can
be explained by the presence of common expanded antigen-
experienced clonotypes recognizing the same antigens, as well as
of high-frequency naïve clonotypes carrying the TCR beta CDR3
sequence variants of low complexity that are repetitively produced
in thymus and may be highly represented both within and between
individuals (15).
In all comparisons, only slightly higher numbers of shared
clonotypes were observed in related versus unrelated mother-child
pairs (Figure 5). This observation is in agreement with the previ-
ous report by Robins et al. where the overlap in the naïve CD8+
CDR3 sequence repertoires was suggested to be independent of
the degree of HLA matching based on results obtained from
three related donors (14). Here, we have achieved a more accu-
rate comparison by studying a larger cohort of related donors,
using unbiased library preparation techniques, sequencing the
samples being compared on separate Illumina lanes to protect
from potential cross-sample contamination on the solid phase
and performing deeper individual profiling. Even with these vari-
ous methodological improvements, we still observed only a subtle
trend toward increased TCR beta repertoire overlap in related
individuals.
However, among the shared high-frequency amino acid CDR3
variants, the percentage of TRBV-CDR3 identical clonotypes was
always higher for related pairs compared to unrelated ones, and
correlated with the number of identical MHC-I alleles (Figure 6).
This finding indicates that optimal recognition of the particular
peptide-MHC complex often requires full functional convergence
of the TCR beta chain, leading to an increased share of TRBV-
identical common CDR3 variants in individuals carrying the same
HLA alleles. Notably, this phenomenon was observed for bulk T
cell populations, where the input of CD8+ T cells was sufficient
to provide correlation. This correlation would probably be much
higher if we were to specifically analyze sorted CD8+ T cells.
SEARCHING FOR PERSISTENT MATURE-MICROCHIMERIC CLONES
In humans, maternal T cells are present in different fetal tissues (46,
48, 51), and may be present in the cord blood at a frequency of
0.1–0.5% of total T cells (48, 52). This can represent hundreds
of thousands or millions of cells, of which many are likely to
be memory T cells (52) capable of further clonal proliferation.
Transmigration of maternal differentiated effector/memory Th1
and Th17 cells through the placenta was recently demonstrated in
mouse models (53). Transfer of mature T cells is also possible in the
opposite direction, and the presence of fetal microchimeric CD4+
and CD8+ T cells was registered in maternal blood during nor-
mal pregnancy in humans, predominantly in the third trimester
(41) when mature α/β T cells are circulating in the fetus at sig-
nificant numbers (54). Such mature-microchimeric T cell clones
could further affect immunity to solid tumors (55, 56), influence
transplantation tolerance (7), cause autoimmune diseases (3, 4,
43, 56–59), or protect the child against infections he/she has never
encountered before.
Recent work has demonstrated that, in general, experienced
clonal T cells commonly persist in the body for many years (17,
60). We have observed more than 20,000 TCR beta clonotypes that
persisted in a patient for at least 7 years – from 2005 until 2012 –
even after the patient underwent autologous HSC transplantation
in 2009 [Ref. (16) and our unpublished data]. Similarly, naïve T
cell clones persist in the body for many years after loss of thymus
functionality (61). Therefore, if the engraftment of mature T cell
clones transferred from mother to child and/or vice versa is a sys-
temic process, we could expect to be able to verify the presence
of such clones by using characteristic TCR beta CDR3 variants as
clonal identifiers.
In our repertoire analysis, we did not observe mature-
microchimeric T cell clones at a level of methodological sensitivity
of ~100 mature-microchimeric clones per 106 analyzed TCR beta
clonotypes. Still, this does not preclude the existence of mature
T cell-based maternal or fetal microchimerism at levels below
the sensitivity achieved in the current study, in minor number
of individuals, or in pathological conditions such as autoimmune
disease.
It should be noted that deep TCR beta profiling methodol-
ogy presently appears to be insufficiently sensitive for identifying
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particular expanded mature-microchimeric T cell clones, due to
the general abundance of common identical TCR beta clonotypes.
The following combination of methods could offer a potential
way forward: (1) deep TCR beta profiling suggesting the pres-
ence of a particular expanded mature-microchimeric T cell clone,
preferably with many added nucleotides within CDR3; (2) cell
sorting using a TRBV family specific antibody in order to enrich
for the hypothetical microchimeric clone of interest; and (3) real-
time PCR confirmation of increased microchimerism in the sorted
sample.
We also believe that further development of NGS profiling
methods – especially in combination with the use of live cell-
based emulsion PCR to identify paired TCR alpha-beta chains (62),
and to potentially identify TCR beta chains paired with specific
HLA molecules serving as an internal marker of microchimeric
clones – should greatly facilitate future studies of mature T cell
microchimerism in health and disease.
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